|
CN111996188A
|
|
Method for performing gene site-directed mutagenesis by using In-Fusion PCR technology
|
|
CN111848747A
|
|
Polypeptide for preventing and/or treating malignant tumor, application and medicament
|
|
CN111863257A
|
|
Serious postpartum hemorrhage risk prediction system and construction method thereof
|
|
CN111529569A
|
|
Composition for treating non-alcoholic fatty liver disease and application
|
|
CN111574339A
|
|
Novel alkyl resorcinol compound and preparation method and application thereof
|
|
CN111518173A
|
|
Polypeptide for treating malignant tumor and preparation method and application thereof
|
|
CN111388656A
|
|
Application of Kallistatin protein in preparation of medicine for preventing and treating OHSS
|
|
CN111518737A
|
|
Ultrasonic response anti-tumor targeting engineering strain construction and in-vitro induction method
|
|
CN111235031A
|
|
Intelligent semen optimization system
|
|
CN111346682A
|
|
Liquid accurate suction proportioning system
|
|
CN111346402A
|
|
Mutual interference prevention suction system
|
|
CN111249611A
|
|
Conductive material extrusion device and conductive material extrusion method
|
|
CN111330095A
|
|
Intelligent negative pressure suction control system
|
|
CN111254162A
|
|
Preparation of cationic lipid microvesicle and mediated gene delivery method thereof
|
|
CN111249471A
|
|
Preparation method of gene-delivered polyethyleneimine nanoparticle microbubble compound
|
|
CN111254116A
|
|
Method for enriching and flow-sorting human ovarian cancer stem cells
|
|
CN110812362A
|
|
Application of adenine in preparing medicine for treating β thalassemia
|
|
CN110974942A
|
|
Pharmaceutical composition, pharmaceutical bag, human-derived composite growth factor composite preparation, and preparation method and application thereof
|
|
CN110964692A
|
|
Stem cell RZSF-SC and establishing method and application thereof
|
|
CN110865184A
|
|
Application of SRSP protein and SRSP epitope peptide and product for diagnosing and treating tumors
|
